BR102014014009B1 - Hidrogel à base de polissacarídeos naturais, processo e usos - Google Patents
Hidrogel à base de polissacarídeos naturais, processo e usos Download PDFInfo
- Publication number
- BR102014014009B1 BR102014014009B1 BR102014014009-3A BR102014014009A BR102014014009B1 BR 102014014009 B1 BR102014014009 B1 BR 102014014009B1 BR 102014014009 A BR102014014009 A BR 102014014009A BR 102014014009 B1 BR102014014009 B1 BR 102014014009B1
- Authority
- BR
- Brazil
- Prior art keywords
- hydrogel
- chitosan
- polysaccharides
- natural polysaccharides
- hydrogels
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 99
- 150000004676 glycans Chemical class 0.000 title claims abstract description 63
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 63
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 22
- 230000008569 process Effects 0.000 title claims abstract description 19
- 229920001661 Chitosan Polymers 0.000 claims abstract description 49
- 244000226021 Anacardium occidentale Species 0.000 claims abstract description 33
- 206010040882 skin lesion Diseases 0.000 claims abstract description 13
- 235000001274 Anacardium occidentale Nutrition 0.000 claims abstract description 9
- 238000013019 agitation Methods 0.000 claims abstract description 9
- 230000000699 topical effect Effects 0.000 claims abstract description 9
- 235000020226 cashew nut Nutrition 0.000 claims description 27
- 239000000499 gel Substances 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 206010061728 Bone lesion Diseases 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 235000011148 calcium chloride Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000013003 healing agent Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 abstract description 15
- 231100000444 skin lesion Toxicity 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000013325 dietary fiber Nutrition 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 230000003902 lesion Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 238000013270 controlled release Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 230000001906 cholesterol absorption Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- -1 1:4 (•) and 2:3 (▲) Polymers 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000007227 biological adhesion Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940042129 topical gel Drugs 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102014014009-3A BR102014014009B1 (pt) | 2014-06-10 | 2014-06-10 | Hidrogel à base de polissacarídeos naturais, processo e usos |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102014014009-3A BR102014014009B1 (pt) | 2014-06-10 | 2014-06-10 | Hidrogel à base de polissacarídeos naturais, processo e usos |
Publications (2)
Publication Number | Publication Date |
---|---|
BR102014014009A2 BR102014014009A2 (pt) | 2017-10-10 |
BR102014014009B1 true BR102014014009B1 (pt) | 2021-11-30 |
Family
ID=62529640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR102014014009-3A BR102014014009B1 (pt) | 2014-06-10 | 2014-06-10 | Hidrogel à base de polissacarídeos naturais, processo e usos |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR102014014009B1 (pt) |
-
2014
- 2014-06-10 BR BR102014014009-3A patent/BR102014014009B1/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR102014014009A2 (pt) | 2017-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Dynamic covalent constructed self-healing hydrogel for sequential delivery of antibacterial agent and growth factor in wound healing | |
Lan et al. | Chitosan/gelatin composite sponge is an absorbable surgical hemostatic agent | |
Pereira et al. | Influence of Aloe vera on water absorption and enzymatic in vitro degradation of alginate hydrogel films | |
US9822223B2 (en) | Method of preparing a composition based on hyaluronic acid | |
US20030148994A1 (en) | Hemostatic composition | |
Padhi et al. | Development of highly biocompatible Gelatin & i-Carrageenan based composite hydrogels: In depth physiochemical analysis for biomedical applications | |
EP3310402B1 (en) | Highly efficacious hemostatic adhesive polymer scaffold | |
Wang et al. | A green method of preparing a natural and degradable wound dressing containing aloe vera as an active ingredient | |
KR101980063B1 (ko) | 히알루론산을 포함하는 스펀지형 생분해성 지혈제 조성물 | |
Ranjbar et al. | Novel chitosan/gelatin/oxidized cellulose sponges as absorbable hemostatic agents | |
Jin et al. | Chitosan/PDLLA-PEG-PDLLA solution preparation by simple stirring and formation into a hydrogel at body temperature for whole wound healing | |
US20180177707A1 (en) | Method of preparing a composition based on hyaluronic acid | |
JP6608421B2 (ja) | セルロース材料の組み合わせ、その製造方法及び使用方法 | |
JP2023024742A (ja) | 高度に有用な止血用接着性ポリマー足場 | |
BR102014014009B1 (pt) | Hidrogel à base de polissacarídeos naturais, processo e usos | |
BR112019001492B1 (pt) | Filamento, composição precursora de filamento e processo de fabricação de um filamento de ácido hialurônico e hidroxiapatita de cálcio | |
Li et al. | A double network hydrogel dressing enhanced by catechin-loaded mesoporous silica for accelerating wound repair in conjunction with red-light therapy | |
Chinh et al. | Fish scale derived collagen/ginsenoside Rb1 biocomposites: preparation, characterization and their hemostatic ability | |
Ismail et al. | Bio-nanocomposite IPN for Biomedical Application | |
BR102019013902A2 (pt) | Processo de produção de esponjas para carreamento de fármacos e absorção de fluidos e esponjas assim produzidas | |
Rao et al. | GO/CaCO3/SiO2 nanocomposite incorporated Carrageenan/Chitosan injectable hydrogel for enhanced hemostasis | |
BR102017022292A2 (pt) | Suspensão de nanoaglomerados de glucosamina derivada da quitosana e processo de obtenção | |
Mushtaq et al. | Injectable Chitosan–Methoxy Polyethylene Glycol Hybrid Hydrogel Untangling the Wound Healing Behavior: In Vitro and In Vivo Evaluation | |
BR102022001614A2 (pt) | Composto de nanoquitosana, óleo vegetal e/ou fosfatos de cálcio e processo de obtenção de composto de nanoquitosana, óleo vegetal e/ou fosfatos de cálcio | |
BR102019010734A2 (pt) | Processo de obtenção de membrana polimérica revestida com nanopartícula para liberação de fármacos para cicatrização cutânea e produto obtido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A ANUIDADE. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B06V | Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/06/2014, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B24D | Patent annual fee: restoration after fee payment | ||
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B24D | Patent annual fee: restoration after fee payment |